A breakthrough new strategy for tumor immune cell therapy A breakthrough new strategy for tumor immune cell therapy. ...
Immunotherapy
Tumor Infiltrating Lymphocytes ( TILs ) in tumor immunotherapy Tumor Infiltrating Lymphocytes ( TILs ) in tumor immunotherapy. Preface Adoptive...
Next-generation tumor immune technology: from immunoomics to single cell analysis and artificial intelligence. Next-generation tumor immune technology: from immunoomics...
Immunotherapy: Interaction between macrophages and other immune cells. Preface Tumor-associated macrophages ( TAM ) are the core...
Will immunotherapy based on NKT cells shine in the future? Will immunotherapy based on NKT cells shine in the...
Science: Knick out this epigenetic gene to make CAR-T more effective Science: Knick out this epigenetic gene to make CAR-T...
Immunotherapy for small cell lung cancer: Comparison between PD-1 and PD-L1 Immunotherapy for small cell lung cancer: Comparison between...
What factors are related to the therapeutic effect of targeted CD19-CAR? The impact factor is as high as 44.5. The...
Understand Heterogeneous myeloid cells in tumors to explore treatment Understand Heterogeneous myeloid cells in tumors to explore treatment. ...
The clinical prospects of immunotherapy for glioblastoma The clinical prospects of immunotherapy for glioblastoma. Preface Glioblastoma multiforme (...
CRISPR/Cas9 and adoptive T cell therapy CRISPR/Cas9 and adoptive T cell therapy. Preface In recent years, adoptive T...
Current status and future of NKT cell immunotherapy Current status and future of NKT cell immunotherapy. Preface At...
How to conduct the genome editing of TCR? How to conduct the genome editing of TCR? 01. Introduce Today, many...
Neoantigens in Tumor Immunotherapy and related cancer vaccines Neoantigens in Tumor Immunotherapy and related cancer vaccines Preface In recent decades,...
Merck Keytruda: Strong efficacy in treating melanoma at all stages! Merck Keytruda: Strong efficacy in treating melanoma at all...
What is the development direction of next-generation tumor immunotherapy? What is the development direction of next-generation tumor immunotherapy? ...
Nature: New CAR-T therapy is expected to target various types of cancer Nature: New CAR-T therapy is expected to...
Cancer immunotherapy: How is the new target DDR1 different? Cancer immunotherapy: How is the new target DDR1 different? ...
What's the pharmacological control of CAR T cells? What's the pharmacological control of CAR T cells? Chimeric antigen receptor (CAR)...
Priming immunity for cold tumors: the combination of local tumor therapy and ICI Priming immunity for cold tumors: the...
Targeted combined immunotherapy is expected to treat metastatic non-small cell lung cancer (NSCLC) Targeted combined immunotherapy is expected to treat...
Top 10 targets of CAR-T development for solid tumors Top 10 targets of CAR-T development for solid tumors. Although CAR-T...
Interaction of next-generation CAR cell therapy with tumors and TME Interaction of next-generation CAR cell therapy with tumors and...
Clinical progress and challenges of personalized neoantigen DC vaccines Clinical progress and challenges of personalized neoantigen DC vaccines. ...
Tumor immunotherapy: What is the difference between CAR-T and TCR-T? Tumor immunotherapy: What is the difference between CAR-T and TCR-T?...
What is the recent progress of Multi-target CAR-T cell therapy? What is the recent progress of Multi-target CAR-T cell therapy?...
Tumor vaccine UV1: 50% of patients survive for more than 5 years! Tumor vaccine UV1: 50% of patients survive...
How does the tumor micro-environment affect immunotherapy? How does the tumor micro-environment affect immunotherapy? Preface The efficacy of tumor immunotherapy...
Why is the toxicity of CAR-T a crucial problem in immunotherapy? Why is the toxicity of CAR-T a crucial...
2021 latest analysis of global CAR-T drugs and future development 2021 latest analysis of global CAR-T drugs and future development. ...
